Eiger Biopharmaceuticals Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the fourth quarter 2023 to a ratio of 5.95, this is below the company average, and notable indication of worsening business environment. Average receivable collection period, for the Eiger Biopharmaceuticals Inc in Dec 31 2023 quarter, has decreased to 61 days, compared to 66 days, in the Sep 30 2023 quarter.

If we take a look into Healthcare sector 324 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Dec 31 2023 from 2539 to 2559.

What is Receivable Turnover Ratio?
What is Eiger Biopharmaceuticals Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

EIGR Receivables Turnover Ratio	(Dec 31 2023) IV. Quarter	(Sep 30 2023) III. Quarter	(Jun 30 2023) II. Quarter	(Mar 31 2023) I. Quarter	(Dec 31 2022) IV. Quarter
Y / Y Receivable Change	-3.83 %	-46.26 %	257.9 %	70.14 %	-32.1 %
Y / Y Revenue Change	41.06 %	-20.25 %	13.49 %	54.06 %	-19.76 %
Receivable Turnover Ratio (TTM)	5.95	5.49	5.24	6.54	7.16
EIGR's Total Ranking	# 2559	# 2539	# 2170	# 2425	# 2500
Accounts Receivable average collection period days	61	66	70	56	51
Seq. Receivable Change	27.33 %	-64.44 %	-4.52 %	122.47 %	-28.84 %
Seq. Revenue Change	18.51 %	-30.89 %	12.75 %	52.74 %	-33 %

Receivable Turnover Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 34
Healthcare Sector	# 325
Overall Market	# 2559

Receivable Turnover Ratio Statistics
High	Average	Low
7.16	6.08	4.93
(Dec 31 2022)		(Mar 31 2022)

EIGR Company Profile • Back to EIGR Efficiency Comparisons • Compare EIGR Receivables Turnover Ratio to its Competitors

Financial Statements
Eiger Biopharmaceuticals Inc 's Accounts Receivable	$ 2 Millions	Visit EIGR's Balance sheet
Eiger Biopharmaceuticals Inc 's Sales TTM	$ 16 Millions	Visit EIGR's Income Statement
Sources of EIGR's Revenues		Visit EIGR's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
EIGR's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
EIGR's Growth Rates	EIGR's Roa	EIGR's Inventory Turnover Ratio	EIGR's Dividend Comparisons
EIGR's Profitability Ratios	EIGR's Roi	EIGR's Asset Turnover Ratio	EIGR's Dividend Growth
EIGR's Valuation Ratios	EIGR's Roe	EIGR's Financial Strength Ratios	EIGR's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2023, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Dec 31 2023	Receivable at quarter ending Dec 31 2023
Orchestra Biomed Holdings Inc	25.56	$ 2.760 Millions	$ 0.108 Millions
Cv Sciences Inc	25.51	$ 15.085 Millions	$ 0.591 Millions
Evotec Se	25.30	$ 875.197 Millions	$ 34.597 Millions
Clearside Biomedical Inc	25.18	$ 8.226 Millions	$ 0.327 Millions
Cano Health Inc	24.48	$ 3,137.757 Millions	$ 128.172 Millions
Qiagen N v	24.37	$ 1,900.688 Millions	$ 77.988 Millions
Plus Therapeutics Inc	24.29	$ 4.913 Millions	$ 0.202 Millions
Inmed Pharmaceuticals Inc	22.64	$ 5.487 Millions	$ 0.242 Millions
Lineage Cell Therapeutics Inc	22.09	$ 8.945 Millions	$ 0.405 Millions
Agenus Inc	21.11	$ 156.314 Millions	$ 7.406 Millions
Kymera Therapeutics Inc	20.96	$ 78.592 Millions	$ 3.750 Millions
Vystar Corporation	20.75	$ 0.526 Millions	$ 0.025 Millions
Editas Medicine Inc	20.64	$ 78.123 Millions	$ 3.784 Millions
Cue Health Inc	20.01	$ 70.936 Millions	$ 3.545 Millions
Quantum Biopharma Ltd	19.91	$ 4.556 Millions	$ 0.229 Millions
Gyre Therapeutics Inc	19.70	$ 113.450 Millions	$ 5.760 Millions
Innovage Holding Corp	19.58	$ 720.796 Millions	$ 36.806 Millions
Jrsis Health Care Corp	19.27	$ 3.939 Millions	$ 0.204 Millions
Kiniksa Pharmaceuticals International Plc	19.17	$ 270.259 Millions	$ 14.095 Millions
Rosecliff Acquisition Corp I	19.08	$ 18.056 Millions	$ 0.946 Millions
Palvella Therapeutics Inc	18.84	$ 42.810 Millions	$ 2.273 Millions
U S Physical Therapy Inc	18.56	$ 487.150 Millions	$ 26.251 Millions
Marizyme Inc	18.31	$ 0.646 Millions	$ 0.035 Millions
Valneva Se	18.11	$ 172.159 Millions	$ 9.509 Millions
Affimed N v	17.87	$ 9.268 Millions	$ 0.519 Millions
Bespoke Extracts Inc	17.46	$ 0.786 Millions	$ 0.045 Millions
Halozyme Therapeutics Inc	17.02	$ 829.253 Millions	$ 48.721 Millions
Qhslab Inc	16.93	$ 1.409 Millions	$ 0.083 Millions
Ensysce Biosciences Inc	16.74	$ 3.229 Millions	$ 0.193 Millions
Wave Life Sciences Ltd	16.14	$ 113.305 Millions	$ 7.022 Millions

Date modified: 2026-09-08T15:11:13+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.